Literature DB >> 9541990

The disposition kinetics, urinary excretion and dosage regimen of amikacin in cross-bred bovine calves.

S P Saini1, A K Srivastava.   

Abstract

The disposition kinetics, urinary excretion and dosage regimen of amikacin after a single intravenous administration of 10 mg/kg was investigated in six cross-bred bovine calves. At 1 min, the concentration of amikacin in the plasma was 116.9 +/- 3.16 micrograms/ml and the minimum therapeutic concentration was maintained for 8 h. The elimination half-life and volume of distribution were 3.09 +/- 0.27 h and 0.4 +/- 0.03 L/kg, respectively. The total body clearance (ClB) and T/P ratio were 0.09 +/- 0.002 L/kg/h and 4.98 +/- 0.41, respectively. Approximately 50% of the total dose of amikacin was recovered in the urine within 24 h after administration. Amikacin in concentrations ranging from 5 to 150 micrograms/ml bound to plasma proteins to the extent of 6.32% +/- 0.42%. A satisfactory intravenous dosage regimen of amikacin in bovine calves would be 13 mg/kg followed by 12 mg/kg at 12 h intervals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541990     DOI: 10.1023/a:1005987212046

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  12 in total

Review 1.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 2.  Pharmacokinetics and molecular modification: implications in drug design and evaluation.

Authors:  R E Notari
Journal:  J Pharm Sci       Date:  1973-06       Impact factor: 3.534

3.  Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum.

Authors:  C M Kunin
Journal:  Clin Pharmacol Ther       Date:  1966 Mar-Apr       Impact factor: 6.875

4.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

5.  Relation between pharmacokinetics of amikacin sulfate and sepsis score in clinically normal and hospitalized neonatal foals.

Authors:  M G Wichtel; B A Breuhaus; D Aucoin
Journal:  J Am Vet Med Assoc       Date:  1992-05-01       Impact factor: 1.936

Review 6.  Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function.

Authors:  A Leroy; G Humbert; G Oksenhendler; J P Fillastre
Journal:  Antibiot Chemother (1971)       Date:  1978

7.  Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.

Authors:  L A Bauer; R A Blouin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.

Authors:  G V Ling; G M Conzelman; C E Franti; A L Ruby
Journal:  Am J Vet Res       Date:  1981-10       Impact factor: 1.156

9.  Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.

Authors:  J A Orsini; L R Soma; J E Rourke; M Park
Journal:  J Vet Pharmacol Ther       Date:  1985-06       Impact factor: 1.786

10.  Clinical pharmacokinetics of amikacin in dogs.

Authors:  J D Baggot; G V Ling; R C Chatfield
Journal:  Am J Vet Res       Date:  1985-08       Impact factor: 1.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.